Cencora’s New Cell and Gene Services Might Change The Case For Investing In Cencora (COR)

Cencora recently launched its Cell and Gene Therapy Enablement service through Accelerate Pharmacy Solutions, aiming to help health systems evaluate, build and scale cell and gene therapy programs by addressing financial, operational and access challenges in a market where more than 35 therapies are FDA-approved and over 1,700 clinical trials are underway.
An interesting angle is that Cencora is moving deeper into higher-value services just as only 4% of health system pharmacy leaders report...